|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/485 | (2006.01) |
| A61K 9/00 | (2006.01) | ||
| A61K 9/22 | (2006.01) | ||
| A61P 25/36 | (2006.01) |
| (11) | Number of the document | 1663229 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04788669.2 |
| Date of filing the European patent application | 2004-09-09 | |
| (97) | Date of publication of the European application | 2006-06-07 |
| (45) | Date of publication and mention of the grant of the patent | 2010-04-14 |
| (46) | Date of publication of the claims translation | 2010-07-26 |
| (86) | Number | PCT/US2004/029521 |
| Date | 2004-09-09 |
| (87) | Number | WO 2005/032555 |
| Date | 2005-04-14 |
| (30) | Number | Date | Country code |
| 506222 P | 2003-09-25 | US |
| (72) |
OSHLACK, Benjamin, US
WRIGHT, Curtis, US
BREDER, Chris, US
|
| (73) |
EURO-CELTIQUE S.A.,
1, rue Jean Piret, 2350 Luxembourg,
LU
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Hidrokodono ir naltreksono farmaciniai deriniai |
| PHARMACEUTICAL COMBINATIONS OF HYDROCODONE AND NALTREXONE |
| Payment date | Validity (years) | Amount | |
| 2017-08-21 | 14 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2018-09-09 |